Innate immune sensing of nucleic acids from mycobacteria

Microbes and Infection

Volumn 16, Issue 12, 2014, Pages 991-997

  Yamashiro, Lívia Harumi ^a,b   Oliveira, Sérgio Costa ^c   Báfica, André ^a,b  

^a Laboratory of Immunobiology Department of Microbiology Immunology and Parasitology   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Acid nucleics; Mycobacteria; Sensors; Tuberculosis

Indexed keywords

BACTERIAL DNA; NUCLEIC ACID; BACTERIAL RNA;

ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL IMMUNITY; CELL POPULATION; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; MACROPHAGE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MYCOBACTERIOSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CORYNEBACTERINEAE;

ANIMALS; DNA, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NUCLEIC ACIDS; RNA, BACTERIAL; SIGNAL TRANSDUCTION;

EID: 84918798687     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.09.006     Document Type: Article

References (86)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 2001, 413:732-738.
3. Arsenault R.J., Li Y., Maattanen P., Scruten E., Doig K., Potter A., et al. Altered toll-like receptor 9 signaling in Mycobacterium avium subsp. paratuberculosis-infected bovine monocytes reveals potential therapeutic targets. Infect Immun 2013, 81(1):226-237.
4. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005, 202(12):1715-1724.
5. Bai W., Liu H., Ji Q., Zhou Y., Liang L., Zheng R., et al. TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. Cell Signal 2014, 26(5):942-950.
6. Bhat N., Fitzgerald K.A. Recognition of cytosolic DNA by cGAS and other STING-dependent sensors. Eur J Immunol 2014, 44(3):634-640.
7. Carvalho N.B., Oliveira F.S., Durães F.V., de Almeida L.a, Flórido M., Prata L.O., et al. Toll-like receptor 9 is required for full host resistance to Mycobacterium avium infection but plays no role in induction of Th1 responses. Infect Immun 2011, 79(4):1638-1646.
8. Cheung B.K.W., Lee D.C.W., Li J.C.B., Lau Y., Lau A.S.Y. A role for double-stranded RNA-activated protein kinase PKR in Mycobacterium-Induced cytokine expression. J Immunol 2005, 175:7218-7225.
9. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 1997, 17(9):503-524.
10. Davila S., Hibberd M.L., Hari Dass R., Wong H.E., Sahiratmadja E., Bonnard C., et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 2008, 4(10):e1000218.
11. de Haro C., Méndez R., Santoyo J. The eIF-2alpha kinases and the control of protein synthesis. FASEB 1996, 10(12):1378-1387.
12. Drennan M.B., Nicolle D., Quesniaux V.J., Jacobs M., Allie N., Mpagi J., et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 2004, 164(1):49-57.
13. Ellis T.N., Kuehn M.J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 2010, 74:81-94.
14. Fenhalls G., Squires G.R., Stevens-Muller L., Bezuidenhout J., Amphlett G., Duncan K., et al. Associations between toll-like receptors and interleukin-4 in the lungs of patients with tuberculosis. Am J Respir Cell Mol Biol 2003, 29:28-38.
15. Fernandes-Alnemri T., Yu J.W., Juliana C., Solorzano L., Kang S., Wu J., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010, 11:385-393.
16. Flynn J.L., Chan J. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 2003, 15(4):450-455. [Review].
17. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jéhanno M., Viala J., et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003, 300:1584.
18. Gorden K.B., Gorski K.S., Gibson S.J., Kedl R.M., Kieper W.C., Qiu X., et al. Synthetic TLR ag- onists reveal functional differences between human TLR7 and TLR8. J Immunol 2005, 174(3):1259-1268.
19. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303(5663):1526-1529.
20. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
21. Hernandez-Pando R., Jeyanathan M., Mengistu G., Aguilar D., Orozco H., Harboe M., et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356:2133-2138.
22. Hölscher C., Reiling N., Schaible U.E., Hölscher A., Bathmann C., Korbel D., et al. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. Eur J Immunol 2008, 38(3):680-694.
23. Hoppstädter J., Diesel B., Zarbock R., Breinig T., Monz D., Koch M., et al. Differential cell reaction upon toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. Respir Res 2010, 11:124.
24. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 26 2009, 458(7237):514-518.
25. Houben D., Demangel C., van Ingen J., Perez J., Baldeón L., Abdallah A.M., et al. ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012, 14(8):1287-1298.
26. Huang Y., Temperley N.D., Ren L., Smith J., Li N., Burt D.W. Molecular evolution of the vertebrate TLR1 gene family-a complex history of gene duplication, gene conversion, positive selection and co-evolution. BMC Evol Biol 2011, 11:149.
27. Imler J.L., Hoffmann J.A. Toll receptors in innate immunity. Rev Trends Cell Biol 2001, 11(7):304-311.
28. Isaacs A., Cox R.A., Rotem Z. Foreign nucleic acids as the stimulus to make interferon. Lancet 20 1963, 2(7299):113-116.
29. Ito T., Schaller M., Hogaboam C.M., Standiford T.J., Chensue S.W., Kunkel S.L. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol 2007, 37(10):2847-2855.
30. Ito T., Schaller M., Hogaboam C.M., Standiford T.J., Sandor M., Lukacs N.W., et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like. J Clin Invest 4 2009, 119(1):33-46.
31. Jackson A.M., Alexandroff A.B., McIntyre M., Esuvaranathan K., James K., Chisholm G.D. Induction of ICAM 1 expression on bladder tumors by BCG immunotherapy. J Clin Pathol 1994, 47:309-312.
32. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998, 161:3042-3049.
33. Janeway C.A. Approaching the asymptote? evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54:1-13.
34. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216. [Review].
35. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles ofMDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101.
36. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21:317-337. 27.
37. Kiemer A.K., Senaratne R.H., Hoppstädter J., Diesel B., Riley L.W., Tabeta K., et al. Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria. J Innate Immun 2009, 1(1):29-45.
38. Kobayashi K., Yuliwulandari R., Yanai H., Naka I., Lien L.T., Hang N.T.L., et al. Association of TLR polymorphisms with development of tuberculosis in Indonesian females. Tissue Antigens 2012, 79(3):190-197.
39. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
40. Kumagai Y., Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010, 125(5):985-992. [Review].
41. Kuo C.C., Kuom C.W., Liang C.M., Liang S.M. A transcriptomic and proteomic analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells. Proteomics 2005, 5:894-906.
42. Lampson G.P., Tytell A.A., Field A.K., Nemes M.M., Hilleman M.R. Inducers of interferon and host resistance. I. double-stranded RNA from extracts of Penicillium funiculosum. Proc Natl Acad Sci U S A 1967, 58(2):782-789.
43. Mao T.K., Lian Z.X., Selmi C., Ichiki Y., Ashwood P., Ansari A.A., et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005, 42:802-808.
44. Master S.S., Rampini S.K., Davis A.S., Keller C., Ehlers S., Springer B., et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 2008, 3:224-232.
45. Matsumoto S., Matsumoto M., Umemori K., Ozeki Y., Furugen M., Tatsuo T., et al. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice. J Immunol 2005, 175(1):441-449. (Baltimore, Md./: 1950).
46. + T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2. PLoS Pathog 2013, 9(6):e1003397.
47. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999, 163:3920-3927.
48. Meijer A.H., Gabby Krens S.F., Medina Rodriguez I.A., He S., Bitter W., Ewa Snaar-Jagalska B., et al. Expression analysis of the toll-like receptor and TIR domain adaptor families of zebrafish. Mol Immunol 2004, 40(11):773-783.
49. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G. Mannosylated liparabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 2001, 166:7477-7485. 104.
50. Ninalga C., Loskog A., Klevenfeldt M., Essand M., Tötterman T.H. CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer. J Immunother 2005, 28(1):20-27.
51. Oldenburg M., Krüger A., Ferstl R., Kaufmann A., Nees G., Sigmund A., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 31 2012, 337(6098):1111-1115.
52. Patel R.C., Stanton P., McMillan N.M., Williams B.R., Sen G.C. The interferon-inducible double-stranded RNA-activated protein kinase self-associates invitro and invivo. Proc Natl Acad Sci U S A 1995, 92(18):8283-8287.
53. Prados-Rosales R., Baena A., Martinez L.R., Luque-Garcia J., Kalscheuer R., Veeraraghavan U., et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest. 2011, 121:1471-1483.
54. Pym A.S., Brodin P., Brosch R., Huerre M., Cole S.T. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002, 46:709-717.
55. Remoli M.E., Giacomini E., Lutfalla G., Dondi E., Orefici G., Battistini A., et al. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J Immunol 2002, 169:366-374.
56. Romilly C., Chevalier C., Marzi S., Masquida B., Geissmann T., Vandenesch F., et al. Loop-loop interactions involved in antisense regulation are processed by the endoribonuclease III in Staphylococcus aureus. RNA Biol 2012, 9(12):1461-1472.
57. Rothfuchs A.G., Bafica A., Feng C.G., Egen J.G., Williams D.L., Brown G.D., et al. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 2007, 179:3463-3471. 135.
58. Russell D.G., VanderVen B.C., Lee W., Abramovitch R.B., Kim M.J., Homolka S., et al. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe. 2010, 8(1):68-76. [Review].
59. Saiga H., Kitada S., Shimada Y., Kamiyama N., Okuyama M., Makino M., et al. Critical role of AIM2 in Mycobacterium tuberculosis infection. Int Immunol 2012, 24(10):637-644.
60. Sander L.E., Davis M.J., Boekschoten M.V., Amsen D., Dascher C.C., Ryffel B., et al. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 22 2011, 474(7351):385-389.
61. Sanjuan M.A., Rao N., Lai K.T.A., Gu Y., Sun S., Fuchs A., et al. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol 2006, 172:1057-1068.
62. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol 2002, 216:65-72.
63. Schafer G., Jacobs M., Wilkinson R.J., Brown G.D. Non- opsonic recognition of Mycobacterium tuberculosis by phagocytes. J Innate Immun 2009, 1:231-243.
64. Shah S., Bohsali A., Ahlbrand S.E., Srinivasan L., Rathinam V.a.K., Vogel S.N., et al. Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system. J Immunol 2013, 191(7):3514-3518. (Baltimore, Md./: 1950).
65. Shimada S., Yano O., Inoue H., Kuramoto E., Fukuda T., Yamamoto H., et al. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J Natl Cancer Inst 1985, 74(3):681-688.
66. Simmons D.P., Canaday D.H., Liu Y., Li Q., Huang A., Boom W.H., et al. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol 2010, 185(4):2405-2415. (Baltimore, Md./: 1950).
67. Smith J., Manoranjan J., Pan M., Bohsali A., Xu J.J., Liu J., et al. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect Immun 2008, 76:5478-5487.
68. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997, 27:1671-1679.
69. Stanley S.A., Raghavan S., Hwang W.W., Cox J.S. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 2003, 100:13001-13006.
70. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24(1):93-103.
71. Tobian A.A., Potter N.S., Ramachandra L., Pai R.K., Convery M., Boom W.H., et al. Alternate class I MHC antigen processing is inhibited by toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003, 171(3):1413-1422.
72. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984, 72(4):955-962.
73. Torres-García D., Cruz-Lagunas A., García-Sancho Figueroa M.C., Fernández-Plata R., Baez-Saldaña R., Mendoza-Milla C., et al. Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med 2013, 11:220.
74. Tsuchiya K., Hara H., Kawamura I., Nomura T., Yamamoto T., Daim S., et al. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J Immunol 2010, 185:1186-1195. 25.
75. Unterholzner L. The interferon response to intracellular DNA: why so many receptors?. Immunobiology 2013, 218(11):1312-1321. [Review].
76. Vabret N., Blander J.M. Sensing microbial RNA in the cytosol. Front Immunol 2013, 4(December):468.
77. van der Wel N., Hava D., Houben D., Fluitsma D., van Zon M., Pierson J., et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007, 129:1287-1298.
78. Velez D.R., Wejse C., Stryjewski M.E., Abbate E., Hulme W.F., Myers J.L., et al. Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet 2010, 127:65-73.
79. Von Meyenn F., Schaefer M., Weighardt H., Bauer S., Kirschning C.J., Wagner H., et al. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells. Immunobiology 2006, 211(6-8):557-565.
80. Watson R.O., Manzanillo P.S., Cox J.S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012, 150:803-815.
81. Whitchurch C.B., Tolker-Nielsen T., Ragas P.C., Mattick J.S. Extracellular DNA required for bacterial biofilm formation. Sci (New York, N.Y.) 2002, 295(5559):1487.
82. Wolf A.J., Linas B., Trevejo-Nuñez G.J., Kincaid E., Tamura T., Takatsu K., et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function invivo. J Immunol 2007, 179(4):2509-2519.
83. World Health Organization Global tuberculosis control: epidemiology, strategy, financing 2013, WHO Report 2013.
84. Yang Y., Zhou X., Kouadir M., Shi F., Ding T., Liu C., et al. The AIM2 inflammasome is involved in macrophage activation during infection with virulent Mycobacterium bovis strain. J Infect Dis 2013, 208(11):1849-1858.
85. Yeung M.C., Liu J., Lau A.S. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci U S A 1996, 93(22):12451-12455.
86. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737.